Release
📈 Stocks
FDA Approves New PREVICOX Tablet Formulation for Boehringer Ingelheim
(7 minutes ago)
Boehringer Ingelheim gains FDA clearance for an improved PREVICOX tablet, offering enhanced dosing flexibility and sustainability benefits for the animal health sector.